Skip to content
2000
Volume 22, Issue 10
  • ISSN: 1567-2050
  • E-ISSN: 1875-5828

Abstract

Introduction

The complement receptor 1 (CR1) gene is identified as the one closely associated with Alzheimer's disease (AD). However, there has been no exploration of the imaging alterations associated with the CR1 gene in AD patients of the Han population. The purpose of this study is to investigate the association between the rs6656401 mutation and neuroimaging variations in Han AD patients.

Methods

We collected nuclear magnetic resonance images from 101 patients with AD and 98 healthy controls (HC). The subjects in this study, based on the different genotypes of rs6656401, were divided into three groups, with the number of AA, AG, and GG genotypes in the AD group being 1, 17, and 83, and 1, 8, and 89 in the HC group. Data were analyzed using the dominant model. Structural differences in the brain tissue between genotypes at the rs6656401 polymorphic locus were compared using voxel-based morphological analysis, cortical thickness, and graph-theoretic analysis to construct structural networks.

Results

Seven regions (namely, right precuneus, right caudal middle frontal cortical, right rostral middle frontal, right superior frontal, right bankssts, right superior parietal, and right paracentral) were significantly different across CR1 rs6656401 genotypes. The voxel-based morphometry analysis revealed that voxel cluster sizes in the left cerebellum, left superior temporal gyrus, right superior frontal gyrus orbital, right precuneus, and right superior parietal were significantly different in the AA, AG, and GG groups. The degree centrality (Dc) of the left inferior frontal gyrus was significantly greater in the GG group than in the AG group after false discovery rate correction in the structural network analysis.

Discussion

This study demonstrates that the rs6656401 AA genotype primarily induces structural alterations in the frontal, temporal, and parietal lobes of AD patients, with significant changes in the right middle frontal gyrus, precuneus, and superior parietal gyrus, along with Dc index alterations in the left inferior frontal gyrus affecting brain network function. Our findings confirm the association between the rs6656401 polymorphism and AD-related brain structural changes, providing the first evidence of these regional alterations in Han Chinese AD cohorts. Future studies will elucidate the locus's pathological mechanism to inform early diagnosis and targeted therapies.

Conclusion

Our study first indicated that CR1 rs6656401 genotypes significantly influenced the morphological and structural covariate networks in Han AD patients.

Loading

Article metrics loading...

/content/journals/car/10.2174/0115672050397092250823195514
2025-09-04
2026-02-28
Loading full text...

Full text loading...

References

  1. KnopmanD.S. AmievaH. PetersenR.C. ChételatG. HoltzmanD.M. HymanB.T. NixonR.A. JonesD.T. Alzheimer disease.Nat. Rev. Dis. Primers.2021713310.1038/s41572‑021‑00269‑y33986301
    [Google Scholar]
  2. 2024 Alzheimer’s disease facts and figures.Alzheimers Dement.20242053708382110.1002/alz.1380938689398
    [Google Scholar]
  3. JiaL. DuY. ChuL. ZhangZ. LiF. LyuD. LiY. LiY. ZhuM. JiaoH. SongY. ShiY. ZhangH. GongM. WeiC. TangY. FangB. GuoD. WangF. ZhouA. ChuC. ZuoX. YuY. YuanQ. WangW. LiF. ShiS. YangH. ZhouC. LiaoZ. LvY. LiY. KanM. ZhaoH. WangS. YangS. LiH. LiuZ. WangQ. QinW. JiaJ. QuanM. WangY. LiW. CaoS. XuL. HanY. LiangJ. QiaoY. QinQ. QiuQ. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: A cross-sectional study.Lancet. Public Health2020512e661e67110.1016/S2468‑2667(20)30185‑733271079
    [Google Scholar]
  4. LedigC. SchuhA. GuerreroR. HeckemannR.A. RueckertD. Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: Biomarker analysis and shared morphometry database.Sci. Rep.2018811125810.1038/s41598‑018‑29295‑930050078
    [Google Scholar]
  5. ScheltensP. BlennowK. BretelerM.M.B. de StrooperB. FrisoniG.B. SallowayS. Van der FlierW.M. Alzheimer’s disease.Lancet20163881004350551710.1016/S0140‑6736(15)01124‑126921134
    [Google Scholar]
  6. PorsteinssonA.P. IsaacsonR.S. KnoxS. SabbaghM.N. RubinoI. Diagnosis of early Alzheimer’s disease: Clinical practice in 2021.J. Prev. Alzheimers Dis.20218337138610.14283/jpad.2021.2334101796
    [Google Scholar]
  7. KhanS. BarveK.H. KumarM.S. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease.Curr. Neuropharmacol.202018111106112510.2174/1570159X1866620052814242932484110
    [Google Scholar]
  8. BatemanR.J. XiongC. BenzingerT.L.S. FaganA.M. GoateA. FoxN.C. MarcusD.S. CairnsN.J. XieX. BlazeyT.M. HoltzmanD.M. SantacruzA. BucklesV. OliverA. MoulderK. AisenP.S. GhettiB. KlunkW.E. McDadeE. MartinsR.N. MastersC.L. MayeuxR. RingmanJ.M. RossorM.N. SchofieldP.R. SperlingR.A. SallowayS. MorrisJ.C. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease.N. Engl. J. Med.2012367979580410.1056/NEJMoa120275322784036
    [Google Scholar]
  9. MatsudaH. MRI morphometry in Alzheimer’s disease.Ageing Res. Rev.201630172410.1016/j.arr.2016.01.00326812213
    [Google Scholar]
  10. WangX. HuangW. SuL. XingY. JessenF. SunY. ShuN. HanY. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease.Mol. Neurodegener.20201515510.1186/s13024‑020‑00395‑332962744
    [Google Scholar]
  11. ZhaoK. LinJ. DyrbaM. WangD. CheT. WuH. WangJ. LiuY. LiS. Coupling of the spatial distributions between sMRI and PET reveals the progression of Alzheimer’s disease.Netw. Neurosci.2023718610110.1162/netn_a_0027137334010
    [Google Scholar]
  12. CaiJ. XiongW. WangX. TanH. Genetic architecture of hippocampus subfields volumes in Alzheimer’s disease.CNS Neurosci. Ther.20243031411010.1111/cns.1411036756718
    [Google Scholar]
  13. LowA. FooH. YongT.T. TanL.C.S. KandiahN. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson’s disease.J. Neurol. Neurosurg. Psychiatry201990668168710.1136/jnnp‑2018‑31959230683708
    [Google Scholar]
  14. SelfW.K. HoltzmanD.M. Emerging diagnostics and therapeutics for Alzheimer disease.Nat. Med.20232992187219910.1038/s41591‑023‑02505‑237667136
    [Google Scholar]
  15. BreijyehZ. KaramanR. Comprehensive review on Alzheimer’s disease: Causes and treatment.Molecules20202524578910.3390/molecules2524578933302541
    [Google Scholar]
  16. LeiP. AytonS. BushA.I. The essential elements of Alzheimer’s disease.J. Biol. Chem.202129610010510.1074/jbc.REV120.00820733219130
    [Google Scholar]
  17. JansenI.E. SavageJ.E. WatanabeK. BryoisJ. WilliamsD.M. SteinbergS. SealockJ. KarlssonI.K. HäggS. AthanasiuL. VoyleN. ProitsiP. WitoelarA. StringerS. AarslandD. AlmdahlI.S. AndersenF. BerghS. BettellaF. BjornssonS. BrækhusA. BråthenG. de LeeuwC. DesikanR.S. DjurovicS. DumitrescuL. FladbyT. HohmanT.J. JonssonP.V. KiddleS.J. RongveA. SaltvedtI. SandoS.B. SelbækG. ShoaiM. SkeneN.G. SnaedalJ. StordalE. UlsteinI.D. WangY. WhiteL.R. HardyJ. Hjerling-LefflerJ. SullivanP.F. van der FlierW.M. DobsonR. DavisL.K. StefanssonH. StefanssonK. PedersenN.L. RipkeS. AndreassenO.A. PosthumaD. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk.Nat. Genet.201951340441310.1038/s41588‑018‑0311‑930617256
    [Google Scholar]
  18. AdewaleQ. KhanA.F. CarbonellF. Iturria-MedinaY. Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer’s disease.eLife2021106258910.7554/eLife.6258934002691
    [Google Scholar]
  19. HoferE. RoshchupkinG.V. AdamsH.H.H. KnolM.J. LinH. LiS. ZareH. AhmadS. ArmstrongN.J. SatizabalC.L. BernardM. BisJ.C. GillespieN.A. LucianoM. MishraA. ScholzM. TeumerA. XiaR. JianX. MosleyT.H. SabaY. PirpamerL. SeilerS. BeckerJ.T. CarmichaelO. RotterJ.I. PsatyB.M. LopezO.L. AminN. van der LeeS.J. YangQ. HimaliJ.J. MaillardP. BeiserA.S. DeCarliC. KaramaS. LewisL. HarrisM. BastinM.E. DearyI.J. Veronica WitteA. BeyerF. LoefflerM. MatherK.A. SchofieldP.R. ThalamuthuA. KwokJ.B. WrightM.J. AmesD. TrollorJ. JiangJ. BrodatyH. WenW. VernooijM.W. HofmanA. UitterlindenA.G. NiessenW.J. WittfeldK. BülowR. VölkerU. PausovaZ. Bruce PikeG. MaingaultS. CrivelloF. TzourioC. AmouyelP. MazoyerB. NealeM.C. FranzC.E. LyonsM.J. PanizzonM.S. AndreassenO.A. DaleA.M. LogueM. GrasbyK.L. JahanshadN. PainterJ.N. Colodro-CondeL. BraltenJ. HibarD.P. LindP.A. PizzagalliF. SteinJ.L. ThompsonP.M. MedlandS.E. GrasbyK.L. JahanshadN. PainterJ.N. Colodro-CondeL. BraltenJ. HibarD.P. LindP.A. PizzagalliF. ChingC.R.K. McMahonM.A.B. ShatokhinaN. ZsembikL.C.P. AgartzI. AlhusainiS. AlmeidaM.A.A. AlnæsD. AmlienI.K. AnderssonM. ArdT. ArmstrongN.J. Ashley-KochA. BernardM. BrouwerR.M. BuimerE.E.L. BülowR. BürgerC. CannonD.M. ChakravartyM. ChenQ. CheungJ.W. Couvy-DuchesneB. DaleA.M. DalvieS. de AraujoT.K. de ZubicarayG.I. de ZwarteS.M.C. den BraberA. DoanN.T. DohmK. EhrlichS. EngelbrechtH-R. ErkS. FanC.C. FedkoI.O. FoleyS.F. FordJ.M. FukunagaM. GarrettM.E. GeT. GiddaluruS. GoldmanA.L. GroenewoldN.A. GrotegerdD. GurholtT.P. GutmanB.A. HansellN.K. HarrisM.A. HarrisonM.B. HaswellC.C. HauserM. HermsS. HeslenfeldD.J. HoN.F. HoehnD. HoffmannP. HolleranL. HoogmanM. HottengaJ-J. IkedaM. JanowitzD. JansenI.E. JiaT. JockwitzC. KanaiR. KaramaS. KasperaviciuteD. KaufmannT. KellyS. KikuchiM. KleinM. KnappM. KnodtA.R. KrämerB. LamM. LancasterT.M. LeeP.H. LettT.A. LewisL.B. Lopes-CendesI. LucianoM. MacciardiF. MarquandA.F. MathiasS.R. MelzerT.R. MilaneschiY. Mirza-SchreiberN. MoreiraJ.C.V. MühleisenT.W. Müller-MyhsokB. NajtP. NakaharaS. NhoK. Olde LoohuisL.M. OrfanosD.P. PearsonJ.F. PitcherT.L. PützB. RagothamanA. RashidF.M. RedlichR. ReinboldC.S. ReppleJ. RichardG. RiedelB.C. RisacherS.L. RochaC.S. MotaN.R. SalminenL. SaremiA. SaykinA.J. SchlagF. SchmaalL. SchofieldP.R. SecolinR. ShaplandC.Y. ShenL. ShinJ. ShumskayaE. SønderbyI.E. SprootenE. StrikeL.T. TanseyK.E. TeumerA. ThalamuthuA. ThomopoulosS.I. Tordesillas-GutiérrezD. TurnerJ.A. UhlmannA. VallergaC.L. van der MeerD. van DonkelaarM.M.J. van EijkL. van ErpT.G.M. van HarenN.E.M. van RooijD. van TolM-J. VeldinkJ.H. VerhoefE. WaltonE. WangM. WangY. WardlawJ.M. WenW. WestlyeL.T. WhelanC.D. WittS.H. WittfeldK. WolfC. WolfersT. YasudaC.L. ZarembaD. ZhangZ. ZhuA.H. ZwiersM.P. ArtigesE. AssarehA.A. Ayesa-ArriolaR. BelgerA. BrandtC.L. BrownG.G. CichonS. CurranJ.E. DaviesG.E. DegenhardtF. DietscheB. DjurovicS. DohertyC.P. EspirituR. GarijoD. GilY. GowlandP.A. GreenR.C. HäuslerA.N. HeindelW. HoB-C. HoffmannW.U. HolsboerF. HomuthG. HostenN. JackC.R. JangM.H. JansenA. KolskårK. KoopsS. KrugA. LimK.O. LuykxJ.J. MathalonD.H. MatherK.A. MattayV.S. MatthewsS. SonJ.M.V. McEwenS.C. MelleI. MorrisD.W. MuellerB.A. NauckM. NordvikJ.E. NöthenM.M. O’LearyD.S. OpelN. MartinotM-L.P. PikeG.B. PredaA. QuinlanE.B. RatnakarV. ReppermundS. SteenV.M. TorresF.R. VeltmanD.J. VoyvodicJ.T. WhelanR. WhiteT. YamamoriH. AlvimM.K.M. AmesD. AndersonT.J. AndreassenO.A. Arias-VasquezA. BastinM.E. BauneB.T. BlangeroJ. BoomsmaD.I. BrodatyH. BrunnerH.G. BucknerR.L. BuitelaarJ.K. BustilloJ.R. CahnW. CalhounV. CaserasX. CaspersS. CavalleriG.L. CendesF. CorvinA. Crespo-FacorroB. Dalrymple-AlfordJ.C. DannlowskiU. de GeusE.J.C. DearyI.J. DelantyN. DepondtC. DesrivièresS. DonohoeG. EspesethT. FernándezG. FisherS.E. FlorH. ForstnerA.J. FrancksC. FrankeB. GlahnD.C. GollubR.L. GrabeH.J. GruberO. HåbergA.K. HaririA.R. HartmanC.A. HashimotoR. HeinzA. HillegersM.H.J. HoekstraP.J. HolmesA.J. HongL.E. HopkinsW.D. Hulshoff PolH.E. JerniganT.L. JönssonE.G. KahnR.S. KennedyM.A. KircherT.T.J. KochunovP. KwokJ.B.J. HellardS.L. MartinN.G. MartinotJ-L. McDonaldC. McMahonK.L. Meyer-LindenbergA. MoreyR.A. NybergL. OosterlaanJ. OphoffR.A. PausT. PausovaZ. PenninxB.W.J.H. PoldermanT.J.C. PosthumaD. RietschelM. RoffmanJ.L. RowlandL.M. SachdevP.S. SämannP.G. SchumannG. SimK. SisodiyaS.M. SmollerJ.W. SommerI.E. PourcainB.S. SteinD.J. TogaA.W. TrollorJ.N. Van der WeeN.J.A. van ’t EntD. VölzkeH. WalterH. WeberB. WeinbergerD.R. WrightM.J. ZhouJ. SteinJ.L. ThompsonP.M. MedlandS.E. SachdevP.S. KremenW.S. WardlawJ.M. VillringerA. van DuijnC.M. GrabeH.J. LongstrethW.T. FornageM. PausT. DebetteS. IkramM.A. SchmidtH. SchmidtR. SeshadriS. Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults.Nat Commun2020111479610.1038/s41467‑020‑18367‑y32963231
    [Google Scholar]
  20. MoonS.W. ZhaoL. MatloffW. HobelS. BergerR. KwonD. KimJ. TogaA.W. DinovI.D. Brain structure and allelic associations in Alzheimer’s disease.CNS Neurosci. Ther.20232941034104810.1111/cns.1407336575854
    [Google Scholar]
  21. ChandraA. DervenoulasG. PolitisM. Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment.J. Neurol.201926661293130210.1007/s00415‑018‑9016‑330120563
    [Google Scholar]
  22. KimJ. JeongM. StilesW.R. ChoiH.S. Neuroimaging modalities in Alzheimer’s disease: Diagnosis and clinical features.Int. J. Mol. Sci.20222311607910.3390/ijms2311607935682758
    [Google Scholar]
  23. MárquezF. YassaM.A. Neuroimaging biomarkers for Alzheimer’s disease.Mol. Neurodegener.20191412110.1186/s13024‑019‑0325‑531174557
    [Google Scholar]
  24. NhoK. NudelmanK. AllenM. HodgesA. KimS. RisacherS.L. ApostolovaL.G. LinK. LunnonK. WangX. BurgessJ.D. Ertekin-TanerN. PetersenR.C. WangL. QiZ. HeA. NeuhausI. PatelV. ForoudT. FaberK.M. LovestoneS. SimmonsA. WeinerM.W. SaykinA.J. Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer’s pathology.Alzheimers Dement.20201691213122310.1002/alz.1209232755048
    [Google Scholar]
  25. JiaJ. NingY. ChenM. WangS. YangH. LiF. DingJ. LiY. ZhaoB. LyuJ. YangS. YanX. WangY. QinW. WangQ. LiY. ZhangJ. LiangF. LiaoZ. WangS. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease.N. Engl. J. Med.2024390871272210.1056/NEJMoa231016838381674
    [Google Scholar]
  26. SintiniI. WhitwellJ.L. Update on neuroimaging in Alzheimer’s disease.Curr. Opin. Neurol.202134452553110.1097/WCO.000000000000094733928929
    [Google Scholar]
  27. LambertJ.C. HeathS. EvenG. CampionD. SleegersK. HiltunenM. CombarrosO. ZelenikaD. BullidoM.J. TavernierB. LetenneurL. BettensK. BerrC. PasquierF. FiévetN. Barberger-GateauP. EngelborghsS. De DeynP. MateoI. FranckA. HelisalmiS. PorcelliniE. HanonO. de PancorboM.M. LendonC. DufouilC. JaillardC. LeveillardT. AlvarezV. BoscoP. MancusoM. PanzaF. NacmiasB. BossùP. PiccardiP. AnnoniG. SeripaD. GalimbertiD. HannequinD. LicastroF. SoininenH. RitchieK. BlanchéH. DartiguesJ.F. TzourioC. GutI. Van BroeckhovenC. AlpérovitchA. LathropM. AmouyelP. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease.Nat. Genet.200941101094109910.1038/ng.43919734903
    [Google Scholar]
  28. HossainR. NoonongK. NuinoonM. Lao-OnU. NorrisC.M. SompolP. RahmanM.A. MajimaH.J. TangpongJ. Alzheimer’s diseases in America, Europe, and Asian regions: A global genetic variation.PeerJ.2024121733910.7717/peerj.1733938756443
    [Google Scholar]
  29. LiY. LawsS.M. MilesL.A. WileyJ.S. HuangX. MastersC.L. GuB.J. Genomics of Alzheimer’s disease implicates the innate and adaptive immune systems.Cell. Mol. Life Sci.202178237397742610.1007/s00018‑021‑03986‑534708251
    [Google Scholar]
  30. TorvellM. CarpaniniS.M. DaskoulidouN. ByrneR.A.J. SimsR. MorganB.P. Genetic insights into the impact of complement in Alzheimer’s disease.Genes20211212199010.3390/genes1212199034946939
    [Google Scholar]
  31. YuanH. DuL. GeP. Complement receptor 1 genetic polymorphism contributes to sporadic Alzheimer’s disease susceptibility in Caucasians: A meta-analysis.Biosci. Rep.2020406BSR2020032110.1042/BSR2020032132432316
    [Google Scholar]
  32. AlmeidaJ.F.F. dos SantosL.R. TrancozoM. de PaulaF. Updated meta-analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 variants in Alzheimer’s disease.J. Mol. Neurosci.201864347147710.1007/s12031‑018‑1045‑y29504051
    [Google Scholar]
  33. LuoJ. LiS. QinX. SongL. PengQ. ChenS. XieY. XieL. LiT. HeY. DengY. WangJ. ZengZ. Meta-analysis of the association between CR1 polymorphisms and risk of late-onset Alzheimer’s disease.Neurosci. Lett.201457816517010.1016/j.neulet.2014.06.05524996192
    [Google Scholar]
  34. ChenL.H. KaoP.Y.P. FanY.H. HoD.T.Y. ChanC.S.Y. YikP.Y. HaJ.C.T. ChuL.W. SongY.Q. Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer’s disease in a southern Chinese population.Neurobiol. Aging2012331210.e1210.e710.1016/j.neurobiolaging.2011.09.01622015308
    [Google Scholar]
  35. JinC. LiW. YuanJ. XuW. ChengZ. Association of the CR1 polymorphism with late-onset Alzheimer’s disease in Chinese Han populations: A meta-analysis.Neurosci. Lett.20125271464910.1016/j.neulet.2012.08.03222960360
    [Google Scholar]
  36. ShenN. ChenB. JiangY. FengR. LiaoM. ZhangL. LiF. MaG. ChenZ. ZhaoB. LiK. LiuG. An updated analysis with 85,939 samples confirms the association between CR1 rs6656401 polymorphism and Alzheimer’s disease.Mol. Neurobiol.20155131017102310.1007/s12035‑014‑8761‑224878768
    [Google Scholar]
  37. ZhuX. DaiW. MaT. Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in Alzheimer’s disease.BMC Med. Genet.202021118110.1186/s12881‑020‑01114‑x32919460
    [Google Scholar]
  38. ZhuX.C. WangH.F. JiangT. LuH. TanM.S. TanC.C. TanL. TanL. YuJ.T. Effect of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts.Mol. Neurobiol.201754155156210.1007/s12035‑015‑9638‑826742530
    [Google Scholar]
  39. ZhuX.C. YuJ.T. JiangT. WangP. CaoL. TanL. CR1 in Alzheimer’s disease.Mol. Neurobiol.201551275376510.1007/s12035‑014‑8723‑824794147
    [Google Scholar]
  40. SunX. DingH. HungK. GuoB. A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS.Nucleic Acids Res.2000281268e6810.1093/nar/28.12.e6810871391
    [Google Scholar]
  41. FischlB. DaleA.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images.Proc. Natl. Acad. Sci. USA20009720110501105510.1073/pnas.20003379710984517
    [Google Scholar]
  42. AshburnerJ. FristonK.J. Voxel-based morphometry--the methods.Neuroimage200011680582110.1006/nimg.2000.058210860804
    [Google Scholar]
  43. WattsD.J. StrogatzS.H. Collective dynamics of ‘small-world’ networks.Nature1998393668444044210.1038/309189623998
    [Google Scholar]
  44. BullmoreE.T. BassettD.S. Brain graphs: Graphical models of the human brain connectome.Annu. Rev. Clin. Psychol.20117111314010.1146/annurev‑clinpsy‑040510‑14393421128784
    [Google Scholar]
  45. ZhuX.C. CaoL. TanM.S. JiangT. WangH.F. LuH. TanC.C. ZhangW. TanL. YuJ.T. Association of Parkinson’s disease GWAS-linked loci with Alzheimer’s disease in han chinese.Mol. Neurobiol.201754130831810.1007/s12035‑015‑9649‑526738859
    [Google Scholar]
  46. ChangH.I. ChangY.T. HuangC.W. HuangK.L. HsuJ.L. HsuS.W. TsaiS.J. ChangW.N. LeeC.C. HuangS.H. ChangC.C. Structural covariance network as an endophenotype in Alzheimer’s disease-susceptible single-nucleotide polymorphisms and the correlations with cognitive outcomes.Front. Aging Neurosci.20211372121710.3389/fnagi.2021.72121734975449
    [Google Scholar]
  47. CrehanH. HoltonP. WrayS. PocockJ. GuerreiroR. HardyJ. Complement receptor 1 (CR1) and Alzheimer’s disease.Immunobiology2012217224425010.1016/j.imbio.2011.07.01721840620
    [Google Scholar]
  48. LuL. YaoQ. RuanS.S. HuJ.W. LongW. DaiW.Z. MaT. ZhuX.C. Explore the role of CR1 genetic variants in late-onset Alzheimer’s disease susceptibility.Psychiatr. Genet.202131621622910.1097/YPG.000000000000029134347684
    [Google Scholar]
  49. LeocadiM. CanuE. PaldinoA. AgostaF. FilippiM. Awareness impairment in Alzheimer’s disease and frontotemporal dementia: A systematic MRI review.J. Neurol.202327041880190710.1007/s00415‑022‑11518‑936512063
    [Google Scholar]
  50. FerreiraD. VerhagenC. Hernández-CabreraJ.A. CavallinL. GuoC.J. EkmanU. MuehlboeckJ.S. SimmonsA. BarrosoJ. WahlundL.O. WestmanE. Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: Longitudinal trajectories and clinical applications.Sci. Rep.2017714626310.1038/srep4626328417965
    [Google Scholar]
  51. HuY. ZhuT. ZhangW. The characteristics of brain atrophy prior to the onset of Alzheimer’s disease: A longitudinal study.Front. Aging Neurosci.202416134492010.3389/fnagi.2024.134492038863784
    [Google Scholar]
  52. ChauveauL. KuhnE. PalixC. FelisattiF. OurryV. de La SayetteV. ChételatG. de FloresR. Medial temporal lobe subregional atrophy in aging and Alzheimer’s disease: A longitudinal study.Front. Aging Neurosci.20211375015410.3389/fnagi.2021.75015434720998
    [Google Scholar]
  53. MofradS.A. LundervoldA.J. VikA. LundervoldA.S. Cognitive and MRI trajectories for prediction of Alzheimer’s disease.Sci. Rep.2021111212210.1038/s41598‑020‑78095‑733483535
    [Google Scholar]
  54. MarinoS. BonannoL. Lo BuonoV. CiurleoR. CoralloF. MorabitoR. ChiricoG. MarraA. BramantiP. Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia.J. Int. Med. Res.201947105019502710.1177/030006051983083031524019
    [Google Scholar]
  55. DuA-T. SchuffN. KramerJ.H. RosenH.J. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.Brain2007130Pt 41159116610.1093/brain/awm016
    [Google Scholar]
  56. WuB.S. ZhangY.R. LiH.Q. KuoK. ChenS.D. DongQ. LiuY. YuJ.T. Cortical structure and the risk for Alzheimer’s disease: A bidirectional Mendelian randomization study.Transl. Psychiatry202111147610.1038/s41398‑021‑01599‑x34526483
    [Google Scholar]
  57. RizviB. LaoP.J. ChesebroA.G. DworkinJ.D. AmaranteE. BeatoJ.M. GutierrezJ. ZahodneL.B. SchupfN. ManlyJ.J. MayeuxR. BrickmanA.M. Association of regional white matter hyperintensities with longitudinal Alzheimer-like pattern of neurodegeneration in older adults.JAMA Netw. Open2021410212516610.1001/jamanetworkopen.2021.2516634609497
    [Google Scholar]
  58. IannopolloE. GarciaK. Enhanced detection of cortical atrophy in Alzheimer’s disease using structural MRI with anatomically constrained longitudinal registration.Hum. Brain Mapp.202142113576359210.1002/hbm.2545533988265
    [Google Scholar]
  59. ColemanM.M. KeithC.M. WilhelmsenK. MehtaR.I. Vieira Ligo TeixeiraC. MillerM. WardM. NaviaR.O. McCuddyW.T. D’HaeseP.F. HautM.W. Surface-based correlates of cognition along the Alzheimer’s continuum in a memory clinic population.Front. Neurol.202314121408310.3389/fneur.2023.121408337731852
    [Google Scholar]
  60. LiJ.Q. WangH.F. ZhuX.C. SunF.R. TanM.S. TanC.C. JiangT. TanL. YuJ.T. GWAS-linked loci and neuroimaging measures in Alzheimer’s disease.Mol. Neurobiol.201754114615310.1007/s12035‑015‑9669‑126732597
    [Google Scholar]
  61. SebeniusI. SeidlitzJ. WarrierV. BethlehemR.A.I. Alexander-BlochA. MallardT.T. GarciaR.R. BullmoreE.T. MorganS.E. Robust estimation of cortical similarity networks from brain MRI.Nat. Neurosci.20232681461147110.1038/s41593‑023‑01376‑737460809
    [Google Scholar]
  62. JiangJ. ZhaoK. LiW. ZhengP. JiangS. RenQ. DuanY. YuH. KangX. LiJ. HuK. JiangT. ZhaoM. WangL. YangS. ZhangH. LiuY. WangA. LiuY. XuJ. Multiomics reveals biological mechanisms linking macroscale structural covariance network dysfunction with neuropsychiatric symptoms across the Alzheimer’s disease continuum.Biol. Psychiatry202597111067107810.1016/j.biopsych.2024.08.02739419461
    [Google Scholar]
  63. ZhengC. ZhaoW. YangZ. TangD. FengM. GuoS. Resolving heterogeneity in Alzheimer’s disease based on individualized structural covariance network.Prog. Neuropsychopharmacol. Biol. Psychiatry202412911087310.1016/j.pnpbp.2023.11087337827426
    [Google Scholar]
  64. GonuguntlaV. YangE. GuanY. KooB.B. KimJ.H. Brain signatures based on structural MRI : Classification for MCI, PMCI, and AD.Hum. Brain Mapp.20224392845286010.1002/hbm.2582035289025
    [Google Scholar]
  65. LiY. SegerC. ChenQ. MoL. Left inferior frontal gyrus integrates multisensory information in category learning.Cereb. Cortex20203084410442310.1093/cercor/bhaa02932133488
    [Google Scholar]
  66. ZhengQ. WangX. Alzheimer’s disease: Insights into pathology, molecular mechanisms, and therapy.Protein Cell.20251628312010.1093/procel/pwae02638733347
    [Google Scholar]
  67. TwarowskiB. HerbetM. Inflammatory processes in Alzheimer’s disease—pathomechanism, diagnosis and treatment: A review.Int. J. Mol. Sci.2023247651810.3390/ijms2407651837047492
    [Google Scholar]
  68. SchjeideBM SchnackC LambertJC LillCM KirchheinerJ TumaniH OttoM TanziRE LehrachH AmouyelP von ArnimCA BertramL The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.Arch. Gen. Psychiatry201168220721310.1001/archgenpsychiatry.2010.19621300948
    [Google Scholar]
  69. NoshenyR.L. InselP.S. MattssonN. TosunD. BuckleyS. TruranD. SchuffN. AisenP.S. WeinerM.W. Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults.Neurobiol. Aging20198211011910.1016/j.neurobiolaging.2019.07.00531437719
    [Google Scholar]
  70. BarthélemyN.R. SalvadóG. SchindlerS.E. HeY. JanelidzeS. CollijL.E. SaefB. HensonR.L. ChenC.D. GordonB.A. LiY. La JoieR. BenzingerT.L.S. MorrisJ.C. Mattsson-CarlgrenN. PalmqvistS. OssenkoppeleR. RabinoviciG.D. StomrudE. BatemanR.J. HanssonO. Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests.Nat. Med.20243041085109510.1038/s41591‑024‑02869‑z38382645
    [Google Scholar]
  71. SerdarC.C. CihanM. YücelD. SerdarM.A. Sample size, power and effect size revisited: Simplified and practical approaches in pre-clinical, clinical and laboratory studies.Biochem. Med.2021311275310.11613/BM.2021.01050233380887
    [Google Scholar]
  72. ZhuJ.D. HuangC.W. ChangH.I. TsaiS.J. HuangS.H. HsuS.W. LeeC.C. ChenH.J. ChangC.C. YangA.C. Functional MRI and ApoE4 genotype for predicting cognitive decline in amyloid-positive individuals.Ther. Adv. Neurol. Disord.2022151756286422113815410.1177/1756286422113815436419870
    [Google Scholar]
  73. HaneyM.S. PálovicsR. MunsonC.N. LongC. JohanssonP.K. YipO. DongW. RawatE. WestE. SchlachetzkiJ.C.M. TsaiA. GuldnerI.H. LamichhaneB.S. SmithA. SchaumN. CalcuttawalaK. ShinA. WangY.H. WangC. KoutsodendrisN. SerranoG.E. BeachT.G. ReimanE.M. GlassC.K. Abu-RemailehM. EnejderA. HuangY. Wyss-CorayT. APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia.Nature2024628800615416110.1038/s41586‑024‑07185‑738480892
    [Google Scholar]
  74. LinE. LinC.H. LaneH.Y. Deep learning with neuroimaging and genomics in Alzheimer’s disease.Int. J. Mol. Sci.20212215791110.3390/ijms2215791134360676
    [Google Scholar]
  75. RostagnoA.A. Pathogenesis of Alzheimer’s Disease.Int. J. Mol. Sci.202224110710.3390/ijms2401010736613544
    [Google Scholar]
  76. Graff-RadfordJ. YongK.X.X. ApostolovaL.G. BouwmanF.H. CarrilloM. DickersonB.C. RabinoviciG.D. SchottJ.M. JonesD.T. MurrayM.E. New insights into atypical Alzheimer’s disease in the era of biomarkers.Lancet. Neurol.202120322223410.1016/S1474‑4422(20)30440‑333609479
    [Google Scholar]
/content/journals/car/10.2174/0115672050397092250823195514
Loading
/content/journals/car/10.2174/0115672050397092250823195514
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test